These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 24083457)
1. Cerebellar motor learning deficits in medicated and medication-free men with recent-onset schizophrenia. Coesmans M; Röder CH; Smit AE; Koekkoek SK; De Zeeuw CI; Frens MA; van der Geest JN J Psychiatry Neurosci; 2014 Jan; 39(1):E3-11. PubMed ID: 24083457 [TBL] [Abstract][Full Text] [Related]
2. Classical eyeblink conditioning and schizophrenia: a short review. Lubow RE Behav Brain Res; 2009 Aug; 202(1):1-4. PubMed ID: 19447273 [TBL] [Abstract][Full Text] [Related]
4. [Cognition, schizophrenia and the effect of antipsychotics]. Stip E Encephale; 2006; 32(3 Pt 1):341-50. PubMed ID: 16840928 [TBL] [Abstract][Full Text] [Related]
5. Impact of antipsychotic treatment on attention and motor learning systems in first-episode schizophrenia. Keedy SK; Reilly JL; Bishop JR; Weiden PJ; Sweeney JA Schizophr Bull; 2015 Mar; 41(2):355-65. PubMed ID: 24894883 [TBL] [Abstract][Full Text] [Related]
6. Effects of haloperidol on cognition in schizophrenia patients depend on baseline performance: a saccadic eye movement study. Babin SL; Hood AJ; Wassef AA; Williams NG; Patel SS; Sereno AB Prog Neuropsychopharmacol Biol Psychiatry; 2011 Aug; 35(7):1753-64. PubMed ID: 21689713 [TBL] [Abstract][Full Text] [Related]
7. Eyeblink conditioning is impaired in subjects with essential tremor. Kronenbuerger M; Gerwig M; Brol B; Block F; Timmann D Brain; 2007 Jun; 130(Pt 6):1538-51. PubMed ID: 17468116 [TBL] [Abstract][Full Text] [Related]
8. Investigating cerebellar neural function in schizophrenia using delay eyeblink conditioning: A pilot fMRI study. Kent JS; Kim DJ; Newman SD; Bolbecker AR; O'Donnell BF; Hetrick WP Psychiatry Res Neuroimaging; 2020 Oct; 304():111133. PubMed ID: 32805441 [TBL] [Abstract][Full Text] [Related]
9. Symptoms, functioning and coping strategies in individuals with schizophrenia spectrum disorders who do not take antipsychotic medication: a comparative interview study. Jung E; Wiesjahn M; Wendt H; Bock T; Rief W; Lincoln TM Psychol Med; 2016 Jul; 46(10):2179-88. PubMed ID: 27269768 [TBL] [Abstract][Full Text] [Related]
10. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation]. Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I Encephale; 2005; 31(2):235-46. PubMed ID: 15959450 [TBL] [Abstract][Full Text] [Related]
11. Secretin effects on cerebellar-dependent motor learning in schizophrenia. Bolbecker AR; Hetrick WP; Johannesen JK; O'Donnell BF; Steinmetz JE; Shekhar AS Am J Psychiatry; 2009 Apr; 166(4):460-6. PubMed ID: 19223439 [TBL] [Abstract][Full Text] [Related]
12. Prepulse inhibition of acoustic startle in subjects with schizophrenia treated with olanzapine or haloperidol. Duncan E; Szilagyi S; Schwartz M; Kunzova A; Negi S; Efferen T; Peselow E; Chakravorty S; Stephanides M; Harmon J; Bugarski-Kirola D; Gonzenbach S; Rotrosen J Psychiatry Res; 2003 Aug; 120(1):1-12. PubMed ID: 14500109 [TBL] [Abstract][Full Text] [Related]
13. Effects of adjunct valproic acid on clinical symptoms and saccadic eye movements in schizophrenia. Larrison AL; Babin SL; Xing Y; Patel SS; Wassef AA; Sereno AB Hum Psychopharmacol; 2011 Oct; 26(7):517-25. PubMed ID: 22031266 [TBL] [Abstract][Full Text] [Related]
14. Efficacy, Acceptability, and Tolerability of Antipsychotics in Treatment-Resistant Schizophrenia: A Network Meta-analysis. Samara MT; Dold M; Gianatsi M; Nikolakopoulou A; Helfer B; Salanti G; Leucht S JAMA Psychiatry; 2016 Mar; 73(3):199-210. PubMed ID: 26842482 [TBL] [Abstract][Full Text] [Related]
15. Smooth pursuit and saccadic abnormalities in first-episode schizophrenia. Hutton SB; Crawford TJ; Puri BK; Duncan LJ; Chapman M; Kennard C; Barnes TR; Joyce EM Psychol Med; 1998 May; 28(3):685-92. PubMed ID: 9626724 [TBL] [Abstract][Full Text] [Related]
16. Randomised controlled trials of conventional antipsychotic versus new atypical drugs, and new atypical drugs versus clozapine, in people with schizophrenia responding poorly to, or intolerant of, current drug treatment. Lewis SW; Davies L; Jones PB; Barnes TR; Murray RM; Kerwin R; Taylor D; Hayhurst KP; Markwick A; Lloyd H; Dunn G Health Technol Assess; 2006 May; 10(17):iii-iv, ix-xi, 1-165. PubMed ID: 16707074 [TBL] [Abstract][Full Text] [Related]
18. Saccadic hypometria in drug-naive and drug-treated schizophrenic patients: a working memory deficit? Hutton SB; Cuthbert I; Crawford TJ; Kennard C; Barnes TR; Joyce EM Psychophysiology; 2001 Jan; 38(1):125-32. PubMed ID: 11321613 [TBL] [Abstract][Full Text] [Related]
19. Does cognitive impairment in treatment-resistant and ultra-treatment-resistant schizophrenia differ from that in treatment responders? Anderson VM; McIlwain ME; Kydd RR; Russell BR Psychiatry Res; 2015 Dec; 230(3):811-8. PubMed ID: 26564550 [TBL] [Abstract][Full Text] [Related]
20. Clozapine versus typical neuroleptic medication for schizophrenia. Wahlbeck K; Cheine M; Essali MA Cochrane Database Syst Rev; 2000; (2):CD000059. PubMed ID: 10796289 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]